Skip to main content
Livermore
Livermore
ZHEN

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Corvus Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CRVS: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders8892+4
Shares36.3M41.8M+5.49M (+15.1%)
Value$115.4M$167.1M+$51.7M (+44.8%)

New holders (33)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CRVS in Q2 2025
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC1,438,595$5.75M0.22%
Gsa Capital Partners LLP318,732$1.27M0.09%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management168,000$672.0K0.02%
BML Capital Management, LLC118,766$475.1K0.36%
Royal Bank of Canada114,954$460.0K0.00%
Bank of New York Mellon Corp110,688$442.8K0.00%
HSBC Holdings PLC84,273$332.0K0.00%
Nuveen, LLC68,064$272.3K0.00%
Deutsche Bank AG43,988$176.0K0.00%
Invesco Ltd.40,607$162.4K0.00%
MetLife Investment Management32,091$128.4K0.00%
Argent Advisors, Inc.30,000$120.0K0.04%
Mirae Asset Global ETFs Holdings Ltd.28,661$114.6K0.00%
Price T Rowe Associates Inc26,299$106.0K0.00%
Intech Investment Management LLC25,778$103.1K0.00%
New York State Common Retirement Fund23,800$95.2K0.00%
Caption Management, LLC21,827$87.3K0.01%
Manufacturers Life Insurance Company, The19,098$76.4K0.00%
Bayesian Capital Management, LP17,500$70.0K0.01%
Alliancebernstein L.P.17,120$68.5K0.00%
Voya Investment Management LLC14,774$59.1K0.00%
ProShare Advisors LLC13,620$54.5K0.00%
Sender Co & Partners, Inc.12,995$52.0K0.01%
Police & Firemen's Retirement System of New Jersey12,258$49.0K0.00%
Resources Investment Advisors, LLC.10,000$40.0K0.00%
Legal & General Group Plc5,833$23.3K0.00%
Ameritas Investment Partners, Inc.5,348$21.4K0.00%
Truvestments Capital LLC4,775$19.1K0.00%
California State Teachers Retirement System3,268$13.1K0.00%
FNY Investment Advisers, LLC2,005$8.00K0.00%
Amalgamated Bank1,789$7.00K0.00%
Comerica Bank365$1.46K0.00%
Sterling Capital Management LLC127$5080.00%

Sold out (29)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of CRVS in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Samlyn Capital, LLC4,065,935$12.9M
Millennium Management LLC1,637,138$5.21M
ExodusPoint Capital Management, LP199,358$634.0K
American Century Companies Inc89,265$283.9K
Omers Administration Corp82,300$261.7K
HRT Financial LP81,927$260.0K
Graham Capital Management, L.P.67,550$214.8K
Citadel Advisors LLC61,676$196.1K
Balyasny Asset Management LLC57,827$183.9K
EntryPoint Capital, LLC53,745$170.9K
Jain Global LLC48,145$153.1K
Jump Financial, LLC45,013$143.1K
Schonfeld Strategic Advisors LLC39,783$126.5K
Quantessence Capital LLC36,421$115.8K
Cannon Global Investment Management, LLC35,000$111.3K
LMR Partners LLP29,858$94.9K
Simplex Trading, LLC26,990$85.0K
Verition Fund Management LLC24,413$77.6K
Dimensional Fund Advisors LP22,793$72.5K
Oppenheimer & Co Inc22,534$71.7K
Quinn Opportunity Partners LLC22,327$71.0K
Brevan Howard Capital Management LP21,738$69.1K
UBS Oconnor LLC20,850$66.3K
Leonteq Securities AG20,000$64.4K
XTX Topco Ltd14,958$47.6K
Capula Management Ltd14,793$47.0K
Capstone Investment Advisors, LLC12,644$40.2K
Group One Trading, L.P.11,895$37.8K
Prelude Capital Management, LLC10,027$31.9K